A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
for Warm Antibody Autoimmune Hemolytic Anemia
Drug: Fostamatinib
8 locations incl. Los Angeles
Sponsor: Rigel Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT04138927·Phase 3·Enrolling By Invitation